- Ortho's new VITROS ® Anti-SARS-CoV-2 IgG Quantitative Test targets the S1 spike protein and is calibrated to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies, which gives clinicians ...
Ortho's Total and IgG COVID-19 Antibody Tests Will Aid in Responsible Back-to-Work Assessment - Ortho receives FDA Emergency Use Authorization for its second COVID-19 antibody test - Similar to ...
- Ortho is the only company that offers laboratories in the U.S. a quantitative test in combination with a nucleocapsid test - Both new antibody tests help health care teams differentiate the cause of ...
Authorized for use in the U.S. in January 2021, Ortho's VITROS® SARS-CoV-2 Antigen Test offers reliable detection of SARS-CoV-2 in patients suspected of COVID-19 by their healthcare provider within ...
RARITAN, N.J., April 13, 2021 /CNW/ — Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced it received CE Marking for its ...
RARITAN, N.J., March 23, 2021 /CNW/ — Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced it received authorization from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results